| 摘要 |
<p>This document provides methods and materials for treating digital ulcers, pulmonary arterial hypertension, vasculitis conditions, inflammatory myositis conditions, or combinations thereof. For example, methods and materials involved in using an inhibitor of a CD40-CD40L interaction to treat digital ulcers, pulmonary arterial hypertension, vasculitis conditions, inflammatory myositis conditions, or combinations thereof are provided.</p> |
